Overexpression of TAGLN2 regulated by non-coding RNAs refering to poor prognosis and tumor immune cell infiltration in hepatocellular carcinoma
Di Zhang(Kingmed Diagnostics), Tian-bing Wang(Anhui Provincial Hospital)
Cited by 0
Related Papers
A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy
|Molecular Cancer Therapeutics|2021|44
Multicenter follow-up study of ankle fracture surgery.
|PubMed|2012|24